The Prognostic Implications of Synchronous Cancers in Breast Cancer Patients
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Synchronous cancers diagnosed with breast cancer impact survival. Bilateral breast cancer offers better outcomes than other synchronous cancers, highlighting the need for tailored screening and treatment.
Area Of Science
- Oncology
- Clinical Research
- Cancer Epidemiology
Background
- Synchronous cancers, diagnosed concurrently with primary breast cancer, present unique prognostic challenges.
- Understanding the impact of secondary malignancies on breast cancer patient outcomes is crucial for effective management.
Purpose Of The Study
- To evaluate the prognostic significance of synchronous cancer diagnoses in patients with initial breast cancer.
- To analyze site-specific survival rates and the relationship between primary breast cancer and secondary cancers.
Main Methods
- Retrospective analysis of 49 patients diagnosed with primary breast cancer and a synchronous secondary cancer within two months.
- Data included demographics, clinical/pathological characteristics, treatment, and follow-up outcomes.
- Statistical analysis utilized Kaplan-Meier curves and Cox regression models.
Main Results
- Contralateral breast cancer (44.9%) and female genital organ cancer (12.24%) were the most common synchronous malignancies.
- Patients with synchronous bilateral breast cancer showed improved overall survival (33 months) versus other synchronous cancers (23.5 months).
- Synchronous non-breast cancers significantly increased the risk of death (HR=1.6, p=0.003).
Conclusions
- Synchronous cancer diagnosis significantly influences breast cancer prognosis.
- Synchronous bilateral breast cancer is associated with better survival compared to other synchronous cancers.
- Findings emphasize the need for vigilant screening and personalized treatment for patients with synchronous malignancies.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Tumors may result in a case where two people have the same mutations in an oncogene or tumor...
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...